Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study

European Journal of Nuclear Medicine

Volumn 26, Issue 12, 1999, Pages 1547-1552

  Grünwald, Frank ^a   Kälicke, Thomas ^b   Feine, Ulrich ^b   Lietzenmayer, Roland ^b   Scheidhauer, Klemens ^b   Dietlein, Markus ^b   Schober, Otmar ^b   Lerch, Hartmut ^b   Brandt Mainz, Katja ^b   Burchert, Wolfgang ^b   Hiltermann, Gerhard ^b   Cremerius, Uwe ^b   Biersack, Hans Jürgen ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

Fluorine 18 fluorodeoxy glucose; Positron emission tomography; Radioiodine; Sestamibi; Thyroid cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOACTIVE IODINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPILLOMA; POSITRON EMISSION TOMOGRAPHY; THYROID CANCER; WHOLE BODY SCINTISCANNING;

FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033457279     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050493     Document Type: Article

References (27)

1. 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997; 7: 327-335.
2. 2. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996; 37: 1468-1472.
3. 3. Grünwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996; 23: 312-319.
4. 4. Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H. Fluorine-18 fluorodeoxy glucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997; 24: 1342-1348.
5. 5. Easton E, Coates D, McKusick A, Borchert R, Zuger J. Concurrent FDG F-18 thyroid PET imaging in 1-131 therapy patients [abstract]. J Nucl Med 1995; 36: 197.
6. 6. Altenvoerde G, Lerch H, Kuwert T, Matheja P, Schäfers M, Schober O. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 1998; 383: 160-163.
7. 7. Sisson JC, Ackermann RJ, Meyer MA. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrin Metabol 1993; 77: 1090-1094.
8. 8. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 1987; 28: 910-914.
9. 9. Schlumberger M, Fragu P, Gardet P, Lumbroso J, Vilot D, Parmentier C. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. Eur J Nucl Med 1991; 18: 153-157.
10. 10. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G. TNM-Atlas. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren. International Union Against Cancer/Union Internationale Contre le Cancer (UICC). Berlin Heidelberg New York: Springer; 1993: 58.
11. 11. Akslen LA. Prognostic importance of histological grading in papillary carcinoma. Cancer 1993; 72: 2680-2685.
12. 12. Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997; 15: 2067-2075.
13. 13. Feine U. Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer. Eur J Endocrinol 1998; 138: 492-496.
14. 14. Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996; 77: 172-180.
15. 15. Grünwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R, Risse J, Biersack HJ. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 1998; 39: 1903-1906.
16. 16. Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Eur J Nucl Med 1995; 22: 1330-1338.
17. 99mTc-MIBI in the follow-up of differentiated thyroid carcinoma. Nuklearmedizin 1991; 30: 115-124.
18. 18. Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P. Tc-99m tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma - preliminary results. Nuklearmedizin 1996; 35: 230-235.
19. 19. Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998; 39: 870-875.
20. 20. Nemec J, Nyvltova O, Blazek T, Vlcek P, Racek P, Novak Z, Preiningerova M, Hubackova M, Krizova M, Zimak J, Bilek R. Positive thyroid cancer scintigraphy using technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1996; 23: 69-71.
21. 21. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
22. 22. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994; 219: 713-725.
23. 23. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994; 35: 104-112.
24. 18F]fluoro-D-glucose in human cancer heterotransplanted in nude mice: comparison between histology and glycolytic status. J Nucl Med 1994; 35: 97-103.
25. 25. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells, mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
26. 99mTc-sestamibi up-take by recurrent Hürthle cell carcinoma of the thyroid. J Nucl Med 1992; 33: 1393-1395.
27. 27. Matthaei S, Trost B, Hamann A, Kausch C, Benecke H, Greten H, Hoppner W, Klein HH. Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes. J Endocrinol 1995; 144: 347-357.